Ledger.Open graph →
SEC Form D · filed November 7, 2023

Kyverna Therapeutics, Inc

Offering
$152.0M
Sold
$152.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Brian Kotzin · Emeryville, CADirectorBeth Spiegelman · Emeryville, CADirectorIan Clark · Tuckahoe, NYDirectorRyan Jones · Montreal, Quebec, CanadaExecKaren Walker · Emeryville, CAExecPeter Maag · West Palm Beach, FLExec · DirectorJames Chung · New York, NYExecDan Spiegelman · Emeryville, CADirectorFred Cohen · Menlo Park, CADirectorSteve Liapis · Emeryville, CADirectorDominic Borie · Emeryville, CAExecBrian Kotzin · Emeryville, CADirectorIan Clark · New Rochelle, NYDirectorRyan Jones · Clearwater Beach, FLExecKaren Walker · Emeryville, CAExecPeter Maag · Emeryville, CAExec · DirectorJames Chung · IRVINE, CAExecDan Spiegelman · Emeryville, CADirectorBeth Spiegelman · Emeryville, CADirectorFred Cohen · Menlo Park, CADirectorSteve Liapis · Emeryville, CADirectorDominic Borie · Emeryville, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗